(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.06%) $0.927
(0.28%) $10.87
(0.07%) $0.793
(-0.16%) $92.43
@ $6.85
Issued: 9 Feb 2024 @ 10:56
Return: -5.40%
Previous signal: Feb 8 - 11:03
Previous signal:
Return: 3.95 %
Live Chart Being Loaded With Signals
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer...
Stats | |
---|---|
Today's Volume | 152 663 |
Average Volume | 258 267 |
Market Cap | 276.94M |
EPS | $0 ( 2024-03-28 ) |
Next earnings date | ( $-0.350 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -6.17 |
ATR14 | $0.0210 (0.33%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-01-04 | Atkins Michael B. | Buy | 35 000 | Stock Option (right to buy) |
2024-01-04 | Atkins Michael B. | Sell | 0 | Common Stock |
2024-01-02 | Trost Timothy W. | Buy | 150 000 | Stock Option (right to buy) |
2024-01-02 | Lubman Ellen | Buy | 131 900 | Stock Option (right to buy) |
2024-01-02 | Isaacs Randi | Buy | 200 000 | Stock Option (right to buy) |
INSIDER POWER |
---|
99.28 |
Last 97 transactions |
Buy: 45 258 272 | Sell: 143 550 934 |
Volume Correlation
Werewolf Therapeutics, Correlation
10 Most Positive Correlations | |
---|---|
RMRM | 0.939 |
APOP | 0.918 |
FEYE | 0.897 |
SVOK | 0.88 |
TLGT | 0.879 |
SVAC | 0.874 |
GAINL | 0.874 |
PAIC | 0.861 |
SYBX | 0.854 |
TDAC | 0.851 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Werewolf Therapeutics, Correlation - Currency/Commodity
Werewolf Therapeutics, Financials
Annual | 2023 |
Revenue: | $19.94M |
Gross Profit: | $18.18M (91.15 %) |
EPS: | $-1.050 |
Q4 | 2023 |
Revenue: | $1.50M |
Gross Profit: | $1.04M (69.35 %) |
EPS: | $-0.330 |
Q3 | 2023 |
Revenue: | $5.90M |
Gross Profit: | $5.45M (92.45 %) |
EPS: | $-0.230 |
Q2 | 2023 |
Revenue: | $8.08M |
Gross Profit: | $7.31M (90.43 %) |
EPS: | $-0.140 |
Financial Reports:
No articles found.
Werewolf Therapeutics,
Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators